Ecthyma gangrenosum is a rare skin infection classically associated with Pseudomonas aeruginosa. We performed a retrospective study of all cases diagnosed with ecthyma gangrenosum from 2004-2010 in a ...

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be ...

The echymotic lesion which developed on her right lateral malleolus, became bullous in the following days and treated as ecthyma gangrenosum. Altough the patient was afebrile with a normal neutrophil ...

InflaRx has taken the difficult decision to abandon its drug development programme, vilobelimab, for rare inflammatory skin disorder pyoderma gangrenosum (PG), a move that has pummelled its share ...

responsible for the unblinded interim analysis of the phase III trial with vilobelimab in pyoderma gangrenosum (PG). The panel recommended stopping the trial due to futility, although no adverse ...

conducting the unblinded interim analysis for the Phase 3 trial for vilobelimab in pyoderma gangrenosum (PG), recommended that the trial be stopped due to futility. This recommendation was based ...

Prof. Niels C. Riedemann, Chief Executive Officer and Founder of InflaRx, said: "We would like to thank the dedicated physicians and pyoderma gangrenosum patients for their participation in this ...

Prof. Niels C. Riedemann, Chief Executive Officer and Founder of InflaRx, said: “We would like to thank the dedicated physicians and pyoderma gangrenosum patients for their participation in this ...

announced Wednesday that the Independent Data Monitoring Committee or IDMC conducting the unblinded interim analysis for the Phase 3 trial for vilobelimab in pyoderma gangrenosum or PG recommended ...

The independent data monitoring committee assessing a phase 3 trial of vilobelimab in pyoderma gangrenosum (PG) has urged InflaRx to stop the study early for futility. The committee made the call ...

Like, we tell people, it's kind of like being the Mr. Glass of skin." Doctors determined he developed pyodermic gangrenosum, a rare inflammatory skin disease that causes large, painful sores on ...